HighFDA (Drugs)·D-0551-2026·2026-06-03
[pending] PRED MILD (PREDNISOLONE ACETATE)
Pending LLM rewrite. Source: FDA_DRUG D-0551-2026.
- Product
- PRED MILD — PRED MILD (PREDNISOLONE ACETATE)
- Category
- Drug
- Distribution
- Distributed nationwide
Recalls
All US Product Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
How to read this listing
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Filters
Minimum severity
101–125 of 3639
- HighFDA (Drugs)·D-0550-2026·2026-06-03
[pending] NICOTINE (NICOTINE)
Pending LLM rewrite. Source: FDA_DRUG D-0550-2026.
- Product
- NICOTINE — NICOTINE (NICOTINE)
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0544-2026·2026-05-27
Erythromycin Tablets Recalled for Impurity Above Acceptable Limits
Zydus Pharmaceuticals is recalling Erythromycin Tablets, 250 mg, nationwide because certain lots contain N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit due to CGMP deviations.
- Product
- ERYTHROMYCIN — ERYTHROMYCIN (ERYTHROMYCIN)
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0538-2026·2026-05-27
Atomoxetine Capsules Recalled Due to Labeling Mix-Up Error
Safecor Health, LLC is recalling Atomoxetine HCl 10 mg capsules because some units are incorrectly labeled as 10 mg when they actually contain 25 mg. Patients taking the mislabeled product may receive an incorrect dose.
- Product
- ATOMOXETINE — ATOMOXETINE (ATOMOXETINE)
- Category
- Drug
- Distribution
- 1 state
- SevereFDA (Drugs)·D-0546-2026·2026-05-27
CIMZIA injection recalled due to lack of sterility assurance
UCB Biosciences is recalling CIMZIA (certolizumab pegol) prefilled syringes nationwide because of a lack of assurance of sterility. Affected lots are distributed across the US.
- Product
- CIMZIA — CIMZIA (CERTOLIZUMAB PEGOL)
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0553-2026·2026-05-27
MG217 Multi-Symptom Treatment Cream recalled for microbial contamination
Wisconsin Pharmacal Company is recalling MG217 Multi-Symptom Treatment Cream & Skin Protectant due to confirmed presence of Staphylococcus aureus contamination. Affected units are 6 oz tubes with Lot #1024088, expiring 11/30/2026, distributed nationwide and in the Bahamas.
- Product
- MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0545-2026·2026-05-27
Erythromycin 500 mg Tablets Recalled for Impurity Above Limits
Zydus Pharmaceuticals is recalling erythromycin 500 mg tablets nationwide due to the presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable intake limit, resulting from manufacturing deviations.
- Product
- ERYTHROMYCIN — ERYTHROMYCIN (ERYTHROMYCIN)
- Category
- Drug
- Distribution
- Distributed nationwide
- HighFDA (Drugs)·D-0541-2026·2026-05-27
Liraglutide Injection Recalled Due to Particulate Matter in Cartridges
Lupin Pharmaceuticals is recalling Liraglutide Injection due to the presence of white thread-like structures (particulate matter) found in cartridges. The recall affects 217,621 pen injectors distributed nationwide.
- Product
- LIRAGLUTIDE — LIRAGLUTIDE (LIRAGLUTIDE)
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0525-2026·2026-05-20
Oasis Tears PF Lubricant Eye Drops Recalled for Sterility Assurance
Oasis Medical, Inc. is recalling Oasis Tears PF preservative-free lubricant eye drops nationwide due to lack of assurance of sterility following FDA observations during an inspection.
- Product
- OASIS TEARS PF — OASIS TEARS PF (GLYCERIN)
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0519-2026·2026-05-13
Octreotide Acetate Injectable Suspension Recalled Due to Sterility Assurance
Teva Pharmaceuticals USA, Inc. is recalling 2,200 kits of Octreotide Acetate for Injectable Suspension (30 mg) due to quality system deficiencies that affect sterility assurance. The recall affects all lots nationwide.
- Product
- OCTREOTIDE ACETATE — OCTREOTIDE ACETATE (OCTREOTIDE ACETATE)
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0524-2026·2026-05-13
TPN Bag Recalled for Missing Insulin Formulation Error
Central Admixture Pharmacy Services is recalling a patient-specific TPN bag because it did not contain insulin as listed on the label. Patients relying on this product for the labeled insulin dosage may face serious health risks.
- Product
- TPN bag (patient specific), Rx# 11-4909703-0-1, Compound Volume 1660 mL per bag, Rx only, Single Dose Injection, Refrigerated Injection, Central Admixture Pharmacy Services, Los Angeles, 13128 Imperial Hwy, Santa Fe Spr., CA 90670
- Category
- Drug
- Distribution
- 1 state
- SevereFDA (Drugs)·D-0540-2026·2026-05-13
Lactated Ringers Injection Recalled for Particulate Matter Contamination
B. Braun Medical Inc. is recalling Lactated Ringer's Injection USP (1000 mL containers) due to the presence of particulate matter. The recall affects 95,412 containers distributed nationwide.
- Product
- LACTATED RINGERS — LACTATED RINGERS (SODIUM CHLORIDE, SODIUM LACTATE, POTASSIUM CHLORIDE, AND CALCIUM CHLORIDE)
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0517-2026·2026-05-13
PurPrep Povidone-Iodine and Isopropyl Alcohol Solution Recalled for Sterility Assurance
CareFusion 213, LLC is recalling PurPrep sterile topical solution due to lack of assurance of sterility and potential product contamination. The affected product is a povidone-iodine and isopropyl alcohol solution distributed nationwide.
- Product
- PURPREP — PURPREP (POVIDONE IODINE AND ISOPROPYL ALCOHOL)
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0513-2026·2026-05-13
DELFLEX Peritoneal Dialysis Solution Recall Due to Potential Sterility Issues
Fresenius Medical Care is recalling DELFLEX Dextrose Peritoneal Dialysis Solution bags due to potential leaks from bag perforations that could compromise sterility. Affected patients should contact their healthcare provider immediately.
- Product
- DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialysis Only, 2.5% DEX. LM/LC, 2L 5PK, Part Number 054-20222, Fresenius Medical Care North America, 920 Winter Street, Waltham, MA 02451.
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0518-2026·2026-05-13
BD PurPrep Povidone-Iodine Topical Solution Sterility Assurance Recall
CareFusion 213, LLC is recalling BD PurPrep (povidone-iodine 8.3% with isopropyl alcohol 72.5%) due to lack of assurance of sterility and potential product contamination. Affected lots are distributed nationwide.
- Product
- PURPREP — PURPREP (POVIDONE IODINE AND ISOPROPYL ALCOHOL)
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0523-2026·2026-05-13
Naproxen Oral Suspension Recalled for Lead and Lithium Contamination
Acella Pharmaceuticals is recalling Naproxen oral suspension due to the presence of lead and lithium above specification levels. The recall affects 6,336 bottles distributed nationwide.
- Product
- NAPROXEN — NAPROXEN (NAPROXEN)
- Category
- Drug
- Distribution
- Distributed nationwide
- HighFDA (Drugs)·D-0512-2026·2026-05-13
DELFLEX Peritoneal Dialysis Solution bags recalled for sterility risk
Fresenius Medical Care is recalling DELFLEX Dextrose Peritoneal Dialysis Solution bags due to potential leaks from perforations that may compromise sterility. The recall affects 37,215 bags distributed nationwide.
- Product
- DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange Set for Intraperitoneal Dialysis Only, 1.5% DEX. LM/LC, 2L 5PK, Part Number 054-20221, Fresenius Medical Care North America, 920 Winter Street, Waltham, MA 02451.
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0492-2026·2026-05-06
GenTeal Tears Lubricant Eye Gel Recalled Due to Sterility Concerns
Alcon Research LLC is recalling GenTeal Tears Lubricant Eye Gel nationwide due to FDA inspection observations indicating the product may lack assurance of sterility. Consumers should not use affected lots.
- Product
- GENTEAL TEARS — GENTEAL TEARS (HYPROMELLOSE)
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0491-2026·2026-05-06
Systane Lubricant Eye Gel Recalled Due to Sterility Concerns
Alcon Research LLC is recalling Systane Lubricant Eye Gel Night Gel (10g) distributed nationwide due to FDA inspection observations regarding lack of assurance of sterility that may impact product quality.
- Product
- SYSTANE — SYSTANE (HYPROMELLOSE)
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0499-2026·2026-05-06
Optase Dry Eye Drops Recalled for Lack of Sterility Assurance
Scope Health is recalling Optase Dry Eye Intense Drops (Glycerin 0.2%) due to lack of assurance of sterility. The product is distributed nationwide.
- Product
- OPTASE — OPTASE (GLYCERIN)
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0489-2026·2026-04-29
Harrow Eye FRESHKOTE Lubricant Eyedrops Sterile 10mL Recall
Harrow Eye LLC is recalling FRESHKOTE Lubricant Eyedrops because the manufacturer cannot guarantee the product remains sterile. Affected lots are 1X68 and 1X69, with an expiration date of 05/31/2027.
- Product
- FRESHKOTE LUBRICANT EYEDROPS, Sterile, 0.33 FL OZ (10mL), Harrow Eye LLC, Nashville, TN USA.
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0496-2026·2026-04-29
Dextrose Injection USP recalled due to sterility assurance concerns
B. Braun Medical Inc. is recalling Dextrose Injection USP 70% in 2000 mL bags nationwide due to lack of assurance of sterility and potential leakage from the diaphragm port after foil removal.
- Product
- DEXTROSE — DEXTROSE (DEXTROSE)
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0495-2026·2026-04-29
Sterile Water for Injection bags recalled due to sterility concerns
B. Braun Medical Inc. is recalling Sterile Water for Injection USP 3000 mL bags (24,928 units) distributed nationwide due to lack of assurance of sterility and potential leakage from the diaphragm port.
- Product
- STERILE WATER — STERILE WATER (WATER)
- Category
- Drug
- Distribution
- Distributed nationwide
- SevereFDA (Drugs)·D-0497-2026·2026-04-29
Sodium Chloride for Irrigation Lacks Sterility Assurance
B. Braun Medical Inc. is recalling sodium chloride for irrigation solution (3000 mL bags) due to lack of assurance of sterility and potential leakage from the diaphragm port. Affected lots distributed nationwide have expiration dates through May 31, 2028.
- Product
- SODIUM CHLORIDE FOR IRRIGATION — SODIUM CHLORIDE FOR IRRIGATION (SODIUM CHLORIDE FOR IRRIGATION)
- Category
- Drug
- Distribution
- Distributed nationwide
- HighFDA (Drugs)·D-0483-2026·2026-04-22
[pending] EPINEPHRINE (EPINEPHRINE)
Pending LLM rewrite. Source: FDA_DRUG D-0483-2026.
- Product
- EPINEPHRINE — EPINEPHRINE (EPINEPHRINE)
- Category
- Drug
- Distribution
- Distributed nationwide